Translational Cancer Imaging
Translational Cancer Imaging
批准号:
9316459
负责人:
Zibo Li
金额:
$15.89万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Academic Medical CentersAnimal ModelAnimalsBasic ScienceBudgetsCancer CenterCancer Center Support GrantCellsClinicalClinical ResearchComputer softwareCustomCyclotronsData Storage and RetrievalDevelopmentEquipmentFundingGoalsGrantHourHumanImageImage AnalysisImage EnhancementIncomeInstitutesLongitudinal StudiesMagnetic Resonance ImagingMalignant NeoplasmsMedical centerMissionMolecularMolecular ProbesMolecular TargetMultimodal ImagingMusPET/CT scanPositron-Emission TomographyProductionRadiochemistryRadiopharmaceuticalsResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch Project GrantsResolutionResource SharingResourcesServicesSpecimenSystemTherapeuticTranslationsUltrasonographyUniversitiesanimal imaginganticancer researchcancer geneticscancer imagingclinical applicationclinical imagingclinical translationfluorescence imagingforesthuman imagingimaging approachimaging capabilitiesimaging modalityimaging probeimaging studyimaging systemimprovedin vivoin vivo imaging systeminnovationinstrumentmembermicroCTmolecular imagingnon-invasive imagingpre-clinicalradiochemicalradiotracerresearch facilitysingle photon emission computed tomographytooltranslational cancer researchtranslational study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT -Translational Cancer Imaging (TCI) Shared Resource
The goal of the Translational Cancer Imaging (TCI) resource is to provide cancer center members with a
comprehensive imaging service that will facilitate basic, clinical, as well as translational cancer research at
UNC. The TCI has expanded from the original Small Animal Imaging Core to include four key units: 1)
Cyclotron & Imaging Probe; 2) Preclinical Imaging; 3) Clinical Research Imaging; and 4) Image Analysis. The
expansion of the imaging core will not only enhance our overall imaging capability, but also greatly expedite
cancer research developed from basic science to clinical application with advanced tools and channels built
within the TCI. The new Cyclotron and Imaging Probe unit contains all the equipment needed to support
radiopharmaceutical development, clinical translation, and probe production for molecular imaging studies.
Key components include state of the art radiochemistry research facility with a high energy (16.5 MeV) GE
PETtrace cyclotron, multiple automated radiochemical processing modules, clean room, hot cells and other
ancillary equipment. The Animal Imaging unit has a new mouse 3,000 cage holding unit and houses eleven
pieces of imaging equipment dedicated for animal studies, including a 9.4T animal MR scanner, one animal
PET/CT scanner, one SPECT/CT scanner, one high resolution microCT for specimens, one microCT systems
for in vivo studies, two high resolution ultrasound system, three IVIS optical imaging systems, and one 3D
tomographic fluorescence imaging system. With all the equipment located in one centralized space, the
preclinical imaging unit is capable of providing non-invasive imaging, longitudinal studies, as well as
multimodality imaging on animal models in various cancer applications. The Human Imaging unit is equipped
with one 3T whole body MRI scanner, one integrated MRI/PET scanner, one PET/CT scanner, and one whole
body 7T MRI scanner, all dedicated for clinical research. Again, they are all located in one centralized space
right above the animal Imaging unit. These dedicated instruments strongly support the translational cancer
research in a seamless fashion. The Image Analysis unit will continue to provide advanced analysis tools,
customized software, and data storage and transfer tools to support imaging studies. For the next funding
cycle, the TCI proposes two major aims, namely 1) to enhance infrastructure for imaging probe services and
translational development; 2) strengthen animal and human imaging support in cancer research. We will
enhance the infrastructure to provide imaging probe development and production services for both preclinical
and clinical usage. Meanwhile, we will continue expanding our imaging capability, improving infrastructures for
translational imaging study, and promoting human imaging research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Catalytic Methods for Efficient Radiolabeling of Un-activated Arene Compounds
-
批准号:10376192
-
项目类别:
-
资助金额:$45.83万
-
财政年份:2020
-
负责人:Zibo Li
-
依托单位:
Novel Catalytic Methods for Efficient Radiolabeling of Un-activated Arene Compounds
-
批准号:10544552
-
项目类别:
-
资助金额:$45.83万
-
财政年份:2020
-
负责人:Zibo Li
-
依托单位:
The development of novel radiation-sensitizer based on ultra-small carbon dots
-
批准号:10650171
-
项目类别:
-
资助金额:$48.93万
-
财政年份:2020
-
负责人:Zibo Li
-
依托单位:
Novel Catalytic Methods for Efficient Radiolabeling of Un-activated Arene Compounds Supplement
-
批准号:10288052
-
项目类别:
-
资助金额:$38.65万
-
财政年份:2020
-
负责人:Zibo Li
-
依托单位:
The development of novel radiation-sensitizer based on ultra-small carbon dots
-
批准号:10454865
-
项目类别:
-
资助金额:$48.96万
-
财政年份:2020
-
负责人:Zibo Li
-
依托单位:
The development of novel radiation-sensitizer based on ultra-small carbon dots
-
批准号:10059478
-
项目类别:
-
资助金额:$52.61万
-
财政年份:2020
-
负责人:Zibo Li
-
依托单位:
The development of novel radiation-sensitizer based on ultra-small carbon dots
-
批准号:10213674
-
项目类别:
-
资助金额:$50.71万
-
财政年份:2020
-
负责人:Zibo Li
-
依托单位:
Development of IDO PET agents for immunotherapy
-
批准号:10304847
-
项目类别:
-
资助金额:$39.6万
-
财政年份:2018
-
负责人:Zibo Li
-
依托单位:
Development of IDO PET agents for immunotherapy
-
批准号:10525243
-
项目类别:
-
资助金额:$39.6万
-
财政年份:2018
-
负责人:Zibo Li
-
依托单位:
Development of IDO PET agents for immunotherapy
-
批准号:10058250
-
项目类别:
-
资助金额:$40.41万
-
财政年份:2018
-
负责人:Zibo Li
-
依托单位:
Small Animal PET/CT for Preclinical Imaging Research
-
批准号:9274662
-
项目类别:
-
资助金额:$83.45万
-
财政年份:2017
-
负责人:Zibo Li
-
依托单位:
Small Animal Imaging Core
-
批准号:9149587
-
项目类别:
-
资助金额:$6.95万
-
财政年份:--
-
负责人:Zibo Li
-
依托单位:
Small Animal Imaging Core
-
批准号:9333270
-
项目类别:
-
资助金额:$11.47万
-
财政年份:--
-
负责人:Zibo Li
-
依托单位:
海外基金